HYALCARE PEG

MRP

MRP 445/-VIAL

Description

• Composition: Sodium Hyaluronate BP 0.15% w/v + Polyethylene Glycol 400 USP 0.4% w/v + Propylene Glycol IP 0.3% w/v + Polyquaternium-1 0.001 % w/v (as preservative) In a buffered aqueous base vehicle q.s.

Doses

• As directed by the Physician

Indication

• Relieves dry eye symptoms
• Provides long-lasting eye lubrication
• Reduces burning and irritation
• Soothes gritty or foreign body sensation
• Helps relieve eye redness due to dryness
• Reduces eye strain from prolonged screen use